 |
|
May 21, 2012
Mark Clayton: Cybersecurity: How US utilities passed up chance to protect their networks
Howard LaFranchi: NATO summit: Who will foot the bill for long-term Afghanistan security?
Chris Farrell : Earn Dividends in Emerging Markets with This WisdomTree ETF
Stephen Whiteside, Ph.D. : Mayo Clinic Medical Edge: Social anxiety disorder --- or just shy?
Guy Jackson : Victim's father regrets death of Lockerbie bomber
The Kosher Gourmet by Mario Batali: Famed chef's veal shoulder farsumagru: A festive meat course for late spring
May 18, 2012
Rabbi Berel Wein: Striving: The People of the Book's Book for (All of) the People
Steven Goldberg: 5 Great Stock Picks and the Exchange-Traded Fund that Owns Them
Mary Pickett, M.D.: Ask the Harvard Experts: Don't be forced into gluten-free lifestyle based merely on a doctor's false-positive test
The Kosher Gourmet by Carolyn Malcoun: DIY healthy lunchbox treats: HOMEMADE FRUIT BARS for kids and brown-bagging adults alike
May 17, 2012
Warren Richey: Teacher fired for being unwed and pregnant can sue religious school, court rules
Josh Mitnick: Netanyahu's 'centrist' coalition is already proving it's anything but
Steven Goldberg: Earn Dividends in Emerging Markets with This WisdomTree ETF
Amina Khan: Research links coffee to lower death rates
The Kosher Gourmet by Faith Duran : Cheesy Potato Breakfast Casserole with Cheddar and Sun-Dried Tomatoes
May 16, 2012
Carmen Terzic, M.D., Ph.D. : Mayo Clinic Medical Edge: A variety of exercises can help improve balance
Melissa Healy: National strategy on Alzheimer's disease aims to halt it by 2025
The Kosher Gourmet by Joyce White : GOODNESS GRACIOUS: GREENS! 4 winning recipes that are no longer just for down-home folks (Includes expert tips & techniques)
May 15, 2012
Kristen Chick: Obama administration resumes arms sales to Bahrain despite serious unresolved human rights issues. Activists feel abandoned
Pat Mertz Esswein: Homes are now affordable again and mortgage rates are low. What you need to know before you buy
Kathy Kristof: Our Practical Investor Fights Inflation with These 6 Investments
Sue Hubbard, M.D.: The Kid's Doctor: Lactose intolerant young child? Check again
The Kosher Gourmet by Kathy Hunt: Spread a Little Excitement with EXOTIC CONDIMENTS (4 RECIPES)
May 14, 2012
Lisa Gerstner: How to Protect Your Identity, Finances If You Lose Your Phone
Harvard Health Letters: Heart disease and dementia
The Kosher Gourmet by Megan Gordon: MANGO COCONUT OAT MORNING MUFFINS are a bright but hearty delight
May 11, 2012
Jessica L. Anderson: Get the Best Deal on a Used Car
Jett Stone: Forget face-lifts and fake knees. Scientists have seen the fountain of youth --- and it's broccoli
The Kosher Gourmet by Chef Mario Batali: The famed chef's vegetable dish that tastes true to the season: FAVAS AND SUGAR SNAP PEAS WITH POTATOES AND TARRAGON
May 10, 2012
Sergei L. Loiko: Putin sends warning to U.S., NATO in Victory Day speech at Red Square
Mary Rourke: How being a 'mentch' got Vidal Sasoon his start and fighting in Israel's War of Independence provided him with confidence and a strong sense of his own identity
Jeff Bertolucci: Get Home Phone Service for Less Than $10 a Month
The Kosher Gourmet by Betty Rosbottom: Gleaming with its golden, crimson, and snowy white hues, this silken smooth and creamy STRAWBERRY ORANGE TRIFLE looks impressive, but is easy to prepare
May 9, 2012
Sharon Palmer, R.D. How you can reduce your risk -- or delay -- chronic diseases associated with aging
|
| |
Jewish World Review
'Holy Grail' of Flu Vaccines by Next Year
By
Jason Koebler
Universal Vaccine Could Be Available by 2013
http://www.JewishWorldReview.com | (USNWR)
Annual flu shots might soon become a thing of the past, and threats such as avian and swine flu might disappear with them as a vaccine touted as the "holy grail" of flu treatment could be ready for human trials next year.
That's earlier than the
National Institutes of Health estimated in 2010, when they said a universal vaccine could be five years off. By targeting the parts of the virus that rarely mutate, researchers believe they can develop a vaccine similar to the mumps or measles shot--people will be vaccinated as children and then receive boosters later.
That differs from the current '60s-era technology, according to Joseph Kim, head of Inovio Pharmaceuticals, which is working on the universal vaccine. Each year, the seasonal flu vaccine targets three or four strains that researchers believe will be the most common that year. Previous seasons' vaccines have no effect on future strains of the virus, because it mutates quickly. The seasonal vaccine also offers no protection against outbreaks, such as 2009's H1N1 swine flu. A universal vaccine would offer protection against all forms of the virus.
| RECEIVE LIBERTY LOVING COLUMNISTS IN YOUR INBOX … FOR FREE! |
| Every weekday JewishWorldReview.com publishes what many in the media and Washington consider "must-reading". HUNDREDS of columnists and cartoonists regularly appear. Sign up for the daily update. It's free. Just click here. |
|
"It's like putting up a tent over your immune system that protects against rapidly mutating viruses," Kim says. At least two other companies are working on a similar vaccine. In late 2010, Inovio earned a
$3.1 million grant from the National Institutes of Health
to work on the vaccine.
"It's a completely different paradigm than how [the vaccines] are made seasonably every year," Kim says.
Kim says early research has been promising. Flu strains fall into different "buckets," he says. All H1N1 strains share similar characteristics, as do all H5N1 strains, including the the Asian bird flu strain that has killed more than 60 percent of the 500 or so people it has infected over the past decade.
Kim says Inovio has already made and completed successful human tests for vaccines that protect against all H1N1 and H5N1 flu strains.
In late 2011, two research groups created a strain of H5N1 bird flu that could be passed from human to human, leading the
World Health Organization
to issue a statement that said they were "deeply concerned about the potential negative consequences" that publishing their research could cause. Some news outlets have called the new strain "engineered doomsday" and wondered whether terrorist organizations could create and distribute a similar virus. Kim says not to worry.
"I am very certain our vaccine can already neutralize that newly made virus," he says. "We're trying to get our hands on it."
Inovio is working on vaccines that'll protect against other strains, such as H3N2, which is seen in a newly-emerged swine flu virus. Those vaccines will be combined with the already-developed H1N1 and H5N1 vaccines to be delivered in one shot by the 2013 flu season. Researchers are taking a similar approach to HIV vaccine development, but working on the flu might be easier.
"Unlike other diseases, we have 50 plus years of diagnostics on the flu," Kim says. "There are lots of toolkits that let us know if our approach will work or not. ... Our goal is to have a vaccine strategy that can protect us from all mutations."
Interested in a private Judaic studies instructor — for free? Let us know by clicking here.
Sign up for the daily JWR update. It's free. Just click here.
To comment, please click here.
© 2012, U.S. News & World Report Distributed by Tribune Media Services.
|
